抗疟疾药物发现的创新:新的目标和道
Neha Jeena1, Lata Panicker2, Inshad Ali Khan1
1Department of Microbiology, Central University of Rajasthan, NH-8, Bandarsindri, Ajmer, 305817, Rajasthan, India.
Current drug targets
|April 21, 2025
概括
由于耐药性,开发新的抗疟疾药物至关重要. 本综述强调了新型药物标和新兴战略,以有效打击疟疾,旨在完全清除寄生虫.
科学领域:
- 医学研究 医学研究
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
背景情况:
- 疟疾控制受到药物耐药性和有限的治疗选择的挑战.
- 现有的抗疟疾药物主要向血液阶段的寄生虫,往往无法消除肝脏阶段的寄生虫.
- 迫切需要具有创新机制的新型抗疟疾药物,以防止公共卫生危机.
研究的目的:
- 审查有前途的药物标,并为下一代抗疟疾药物提供主要候选剂.
- 提供关于临床验证的标和正在开发中的候选药物的最新信息.
- 探索用于增强疟疾治疗的新兴治疗策略.
主要方法:
- 对当前抗疟疾药物开发的文献综述.
- 在Plasmodium中探索新的药物标.
- 在临床试验中对抗疟疾候选药物的分析.
主要成果:
- 确定了包括血红素排毒,食物真空,线粒体和P型ATPases在内的关键目标.
- 讨论了潜在的下一代抗疟疾治疗的主要候选人.
- 突出了临床开发和新兴策略的进展,如准载体和蛋白质网络.
结论:
- 更深入地了解Plasmodium通路对于提高药物疗效和缓解耐药性至关重要.
- 新的治疗策略为开发持久的抗疟疾疗法提供了新的途径.
- 对创新的抗疟疾药物开发的持续研究对于全球疟疾控制至关重要.
相关概念视频
Drug Discovery: Overview
7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K
Targets for Drug Action: Overview
5.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.9K


